Profilo
Gerard Chia is currently a Board Member at ViAqua Therapeutics Ltd. since 2018 and a Partner at Clay Capital since 2019.
Former roles include Analyst at Aquilus Pte.
Ltd. from 2012 to 2016 and Investment Analyst at PT Saratoga Capital.
Education includes an undergraduate degree from the University of London.
Posizioni attive di Gerard Chia
| Società | Posizione | Inizio |
|---|---|---|
Clay Capital
Clay Capital Investment ManagersFinance Clay Capital invests in companies located across Europe and Asia. The firm focuses on the food & agritech sectors. It provides financing for seed to series C capital requirements. | Investitore di Private Equity | 01/01/2015 |
ViAqua Therapeutics Ltd.
ViAqua Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Develops orally administered supplements in aquaculture to prevent viral epidemics | Direttore/Membro del Consiglio | 01/01/2018 |
Precedenti posizioni note di Gerard Chia
| Società | Posizione | Fine |
|---|---|---|
Aquilus Pte. Ltd.
Aquilus Pte. Ltd. Financial ConglomeratesFinance Provides investment services | Corporate Officer/Principal | 31/01/2016 |
PT Saratoga Capital
PT Saratoga Capital Financial ConglomeratesFinance Alternative investment manager | Corporate Officer/Principal | - |
Formazione di Gerard Chia
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aquilus Pte. Ltd.
Aquilus Pte. Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
PT Saratoga Capital
PT Saratoga Capital Financial ConglomeratesFinance Alternative investment manager | Finance |
Clay Capital
Clay Capital Investment ManagersFinance Clay Capital invests in companies located across Europe and Asia. The firm focuses on the food & agritech sectors. It provides financing for seed to series C capital requirements. | Finance |
ViAqua Therapeutics Ltd.
ViAqua Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Develops orally administered supplements in aquaculture to prevent viral epidemics | Health Technology |
















